Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
Authors:
Open Access
- 1 November 2022
- journal article
- research article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 86 (Pt 3) , 769-781
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- National Key Research and Development Program of China Stem Cell and Translational Research
This publication has 187 references indexed in Scilit:
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cellsCellular Signalling, 2013
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16BNature Medicine, 2012
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- Differential macrophage programming in the tumor microenvironmentTrends in Immunology, 2012
- p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotypeThe EMBO Journal, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cellsHepatology, 2010
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathwaysOncogene, 2010
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretionNature Cell Biology, 2009